Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and the past week was populated with a host of riveting news and features from the life …
News

NICE U-turns to recommend Sanofi Gaucher disease drug

June 2, 2017 Medical Communications, Sales and Marketing Gaucher disease, NICE, Sanofi

It has been revealed that NICE has reached the decision to recommend Sanofi’s Cerdelga (eligustat) for use on the NHS …
News

Clinical Trial Success: How Relationships Are Key

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing contract research organisations, cros

Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …
Feature
White paper
hoffman

Silence Therapeutics instate new COO

June 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics

Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …
Appointment

Europe vs USA: New drug approvals

June 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, regulatory affairs

Dr Terese Johansson, Regulatory Affairs Consultant NDA Group AB, examines the drop in US approvals while observing no similar trend …
Feature
White paper
640px-palace_of_westminster_at_night

What the life sciences industry wants from the next UK government

June 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, UK, general election, life sciences

The stakes are high as the UK general election draws ever closer, and the industry has come out in force …
Feature
1280px-epi-pen_1

Mylan overcharged for EpiPen by $1.7 billion, new report says

June 1, 2017 Sales and Marketing Mylan, epipen

More bad news for Mylan as a new report from the Department of Health and Human Services’ Office of the …
News
european_commission_web

New biosimilar guidelines launched in the EU

June 1, 2017 Medical Communications, Research and Development, Sales and Marketing EMA, biosimilars

A joint effort by the EMA and the European Commission has seen the publication of a biosimilar information guide for …
News

Navigating the challenges of health technology assessment

May 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI, Global Pricing Innovations

In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …
Feature
Case study
joe-ciaffoni-biogen-750xx2574-1445-0-143

Collegium bring in former Biogen SVP as new COO

May 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Collegium pharmaceutical

Collegium Pharmaceutical has announced the appointment of Joseph Ciaffoni to the position of Executive Vice President and Chief Operating Officer. …
Appointment
shutterstock_46732501

Could robots solve the pharma talent crisis?

May 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …
Feature
fdaoutsideweb

FDA approves first generic versions of Lilly’s ADHD drug

May 31, 2017 Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva

The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …
News
novartis_window

Mounting US pricing pressures cutting into quarterly sales, Novartis admits

May 31, 2017 Research and Development, Sales and Marketing Novartis, Sandoz

Novartis has revealed that increasing pressure on pricing in the US has impacted its second-quarter business, cutting into sales generated …
News
shutterstock_273326141

BMS and Array BioPharma partner up to tackle colorectal cancer

May 30, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Array Biopharma, BMS, Bristol-Myers Squibb

Bristol-Myers Squibb and Array BioPharma have announced they are to join forces as part of a new clinical research partnership …
News

Glenmark greenlighted to market hypertension generic in US

May 30, 2017 Manufacturing and Production, Sales and Marketing FDA, Glenmark, generic, hypertension

Glenmark Pharmaceuticals has revealed it has been awarded final approval by the FDA to market hypertension treatment nebivolol, a generic …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026